Evoke Pharma Inc Underwriting Agreements
7 Contracts & Agreements
- Underwriting Agreement, dated February 8, 2024, by and among Evoke Pharma, Inc., Craig-Hallum Capital Group LLC and Laidlaw & Company (UK) Ltd (Filed With SEC on February 9, 2024)
- Underwriting Agreement (Filed With SEC on January 11, 2024)
- Underwriting Agreement (Filed With SEC on December 15, 2023)
- Underwriting Agreement, dated January 13, 2021, by and between Evoke Pharma, Inc. and Laidlaw &Company (UK) Ltd (Filed With SEC on January 14, 2021)
- 2,413,793 Shares EVOKEPHARMA, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on February 16, 2017)
- UNDERWRITING AGREEMENT between EVOKE PHARMA, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters EVOKE PHARMA, INC. UNDERWRITING AGREEMENT (Filed With SEC on August 30, 2013)
- UNDERWRITING AGREEMENT between EVOKE PHARMA, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters EVOKE PHARMA, INC. UNDERWRITING AGREEMENT (Filed With SEC on August 16, 2013)
